Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:05 pm Unchanged | 2024-02-14 | 13G | SAB Biotherapeutics, Inc. SABS | Commodore Capital LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-14 4:05 pm Unchanged | 2024-02-14 | 13G | Viridian Therapeutics, Inc. VRDN | Commodore Capital LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-14 4:05 pm Unchanged | 2024-02-14 | 13G | Vera Therapeutics, Inc. VERA | Commodore Capital LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-01-19 4:05 pm Unchanged | 2024-01-19 | 13G | Adicet Bio, Inc. ACET | Commodore Capital LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-12-22 4:05 pm Unchanged | 2023-12-22 | 13G | C4 Therapeutics, Inc. CCCC | Commodore Capital LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-12-01 4:15 pm Unchanged | 2023-12-01 | 13G | Spyre Therapeutics, Inc. SYRE | Commodore Capital LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-11-03 4:05 pm Unchanged | 2023-11-03 | 13G | Harpoon Therapeutics, Inc. HARP | Commodore Capital LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-10-27 4:05 pm Unchanged | 2023-10-27 | 13G | Nkarta, Inc. NKTX | Commodore Capital LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-10-16 4:05 pm Unchanged | 2023-10-16 | 13G | SAB Biotherapeutics, Inc. SABS | Commodore Capital LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-10-12 4:05 pm Unchanged | 2023-10-12 | 13G | Soleno Therapeutics, Inc. SLNO | Commodore Capital LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-10-06 4:05 pm Unchanged | 2023-10-06 | 13G | VistaGen Therapeutics, Inc. VTGN | Commodore Capital LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-08-09 4:15 pm Unchanged | 2023-08-09 | 13G | VistaGen Therapeutics, Inc. VTGN | Commodore Capital LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-04-27 4:05 pm Unchanged | 2023-04-27 | 13G | Ambrx Biopharma Inc. AMAM | Commodore Capital LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-04-24 4:05 pm Unchanged | 2023-04-24 | 13G | Enliven Therapeutics, Inc. ELVN | Commodore Capital LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-04-20 4:05 pm Unchanged | 2023-04-20 | 13G | Adverum Biotechnologies, Inc. ADVM | Commodore Capital LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-03-30 4:05 pm Unchanged | 2023-03-30 | 13G | BELLUS Health Inc. BLU | Commodore Capital LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-03-03 4:10 pm Unchanged | 2023-03-03 | 13G | Ambrx Biopharma Inc. AMAM | Commodore Capital LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-03-03 4:05 pm Unchanged | 2023-03-03 | 13G | Ambrx Biopharma Inc. AMAM | Commodore Capital LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-28 4:05 pm Unchanged | 2023-02-28 | 13G | Enliven Therapeutics, Inc. ELVN | Commodore Capital LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-21 4:05 pm Unchanged | 2023-02-21 | 13G | Enliven Therapeutics, Inc. ELVN | Commodore Capital LP | 0 0.000% | 0 (Unchanged) | Filing |